Annual Total Liabilities
$10.69 M
+$513.00 K+5.04%
December 31, 2023
Summary
- As of March 13, 2025, CGTX annual total liabilities is $10.69 million, with the most recent change of +$513.00 thousand (+5.04%) on December 31, 2023.
- During the last 3 years, CGTX annual total liabilities has fallen by -$64.61 million (-85.81%).
- CGTX annual total liabilities is now -85.81% below its all-time high of $75.30 million, reached on December 31, 2020.
Performance
CGTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$13.10 M
+$1.74 M+15.29%
September 30, 2024
Summary
- As of March 13, 2025, CGTX quarterly total liabilities is $13.10 million, with the most recent change of +$1.74 million (+15.29%) on September 30, 2024.
- Over the past year, CGTX quarterly total liabilities has increased by +$3.25 million (+33.02%).
- CGTX quarterly total liabilities is now -87.03% below its all-time high of $100.97 million, reached on June 30, 2021.
Performance
CGTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CGTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.0% | +33.0% |
| 3 y3 years | -85.8% | +33.0% |
| 5 y5 years | -83.8% | +33.0% |
CGTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.9% | -8.0% | +66.5% |
| 5 y | 5-year | -85.8% | +35.9% | -87.0% | +66.5% |
| alltime | all time | -85.8% | +35.9% | -87.0% | +66.5% |
Cognition Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.10 M(+15.3%) |
| Jun 2024 | - | $11.36 M(+13.7%) |
| Mar 2024 | - | $9.99 M(-6.5%) |
| Dec 2023 | $10.69 M(+5.0%) | $10.69 M(+8.6%) |
| Sep 2023 | - | $9.85 M(+2.8%) |
| Jun 2023 | - | $9.57 M(-3.1%) |
| Mar 2023 | - | $9.88 M(-2.9%) |
| Dec 2022 | $10.18 M | $10.18 M(-28.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $14.24 M(+59.7%) |
| Jun 2022 | - | $8.91 M(-10.5%) |
| Mar 2022 | - | $9.96 M(+26.6%) |
| Dec 2021 | $7.86 M(-89.6%) | $7.86 M(-92.1%) |
| Sep 2021 | - | $100.11 M(-0.9%) |
| Jun 2021 | - | $100.97 M(+19.7%) |
| Mar 2021 | - | $84.37 M(+12.0%) |
| Dec 2020 | $75.30 M(+14.3%) | $75.30 M |
| Dec 2019 | $65.88 M | - |
FAQ
- What is Cognition Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Cognition Therapeutics?
- What is Cognition Therapeutics annual total liabilities year-on-year change?
- What is Cognition Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly total liabilities year-on-year change?
What is Cognition Therapeutics annual total liabilities?
The current annual total liabilities of CGTX is $10.69 M
What is the all time high annual total liabilities for Cognition Therapeutics?
Cognition Therapeutics all-time high annual total liabilities is $75.30 M
What is Cognition Therapeutics annual total liabilities year-on-year change?
Over the past year, CGTX annual total liabilities has changed by +$513.00 K (+5.04%)
What is Cognition Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CGTX is $13.10 M
What is the all time high quarterly total liabilities for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly total liabilities is $100.97 M
What is Cognition Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CGTX quarterly total liabilities has changed by +$3.25 M (+33.02%)